These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10587702)

  • 1. A reappraisal of the histopathologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease.
    Massi D; Franchi A; Pimpinelli N; Laszlo D; Bosi A; Santucci M
    Am J Clin Pathol; 1999 Dec; 112(6):791-800. PubMed ID: 10587702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.
    Fischer A; Jakubowski AA; Lacouture ME; Hollmann TJ; Drucker AM; Maloy M; Prockop S; Querfeld C; Busam KJ; Pulitzer MP
    Am J Dermatopathol; 2015 Jul; 37(7):523-9. PubMed ID: 26091510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature.
    Esteban JM; Somlo G
    Mod Pathol; 1995 Jan; 8(1):59-64. PubMed ID: 7731943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers.
    Atkinson K; Horowitz MM; Biggs JC; Gale RP; Rimm AA; Bortin MM
    Bone Marrow Transplant; 1988 Jan; 3(1):5-10. PubMed ID: 3048470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.
    Horn TD; Zahurak ML; Atkins D; Solomon AR; Vogelsang GB
    Arch Dermatol; 1997 Aug; 133(8):961-5. PubMed ID: 9267240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions.
    Weaver J; Bergfeld WF
    Am J Dermatopathol; 2010 Feb; 32(1):31-4. PubMed ID: 19730082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease.
    Salmela MT; Karjalainen-Lindsberg ML; Jeskanen L; Saarialho-Kere U
    Mod Pathol; 2003 Feb; 16(2):108-14. PubMed ID: 12591962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery.
    Bauer DJ; Hood AF; Horn TD
    Arch Dermatol; 1993 Jul; 129(7):855-8. PubMed ID: 8323305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The skin biopsy in the diagnosis of acute graft-versus-host disease in man.
    Sale GE; Lerner KG; Barker EA; Shulman HM; Thomas ED
    Am J Pathol; 1977 Dec; 89(3):621-36. PubMed ID: 23008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards an objective prognostic index of acute graft-versus-host disease.
    Sahmoud TM; Heudes D; Irinopoulou T; Gluckman E; Nguyen Q; Brocheriou C; Devergie A; Rigaut JP; Mary JY
    Anal Cell Pathol; 1993 Sep; 5(5):289-97. PubMed ID: 8217909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
    Uberti JP; Ayash L; Ratanatharathorn V; Silver S; Reynolds C; Becker M; Reddy P; Cooke KR; Yanik G; Whitfield J; Jones D; Hutchinson R; Braun T; Ferrara JL; Levine JE
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):680-7. PubMed ID: 16125638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
    Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M
    Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
    Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
    Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients.
    Segura S; Pujol RM; Trindade F; Requena L
    J Am Acad Dermatol; 2008 Nov; 59(5):839-51. PubMed ID: 19119100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE; McKee PH; Nghiem P
    J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical acute graft-versus-host disease.
    Shin J; Hong W; Song H; Choi G; Kim YC
    Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.
    Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
    Bone Marrow Transplant; 2003 Oct; 32(8):777-84. PubMed ID: 14520421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
    Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.